Patents by Inventor Giovanni Scapagnini

Giovanni Scapagnini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11953493
    Abstract: The present technology generally relates to a method for modulating in situ production of energy by a biological tissue. The method comprises stimulating the biological tissue by exposing the biological tissue to a photostimulated biophotonic composition for a time sufficient to initiate the production of energy by the biological tissue.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: April 9, 2024
    Assignee: FLE INTERNATIONAL S.R.L.
    Inventors: Nikolaos Loupis, Remigio Piergallini, David Ohayon, Lise Hébert, Giovanni Scapagnini
  • Publication number: 20220111050
    Abstract: The present document describes methods of using compositions for inhibiting biofilm formation, or disrupting existing or developing biofilms in a subject, which composition comprises at least one chromophore and a pharmacologically acceptable carrier.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: Remigio PIERGALLINI, Nikolaos LOUPIS, David OHAYON, Kevin WILKINSON, Giovanni SCAPAGNINI
  • Patent number: 11207408
    Abstract: The present document describes methods of using compositions for inhibiting biofilm formation, or disrupting existing or developing biofilms in a subject, which composition comprises at least one chromophore and a pharmacologically acceptable carrier.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: December 28, 2021
    Assignee: KLOX TECHNOLOGIES INC.
    Inventors: Remigio Piergallini, Nikolaos Loupis, David Ohayon, Kevin Wilkinson, Giovanni Scapagnini
  • Publication number: 20200222536
    Abstract: The present disclosure provides biophotonic compositions comprising one or more fungal-derived chromophores and methods useful in phototherapy. In particular, the biophotonic compositions and the methods of the present disclosure are useful for the treatment of rare diseases that afflict skin or soft tissues. The present disclosure also provides a photoactivatable fabric composition in combination with the biophotonic compositions.
    Type: Application
    Filed: May 23, 2017
    Publication date: July 16, 2020
    Inventors: Francesco BELLINI, Nikolaos LOUPIS, Remigio PIERGALLINI, Andreas NIKOLIS, Giovanni SCAPAGNINI
  • Publication number: 20190381173
    Abstract: According to various aspects, the present technology provides for the use of fluorescence generated and emitted from a biophotonic composition or system, wherein said fluorescence results from induction of one or more light-absorbing molecules found in the composition or system, wherein said emitted fluorescence is reaching a cell or tissue in order to modulate one or more biological processes within said cell or tissue.
    Type: Application
    Filed: January 26, 2018
    Publication date: December 19, 2019
    Inventors: Michael CANOVA ENGELBRECHT NIELSEN, Remigio PIERGALLINI, Nikolaos LOUPIS, Joanna JAWORSKA, Emmanuelle DEVEMY, Giovanni SCAPAGNINI
  • Publication number: 20190360993
    Abstract: The present technology generally relates to a method for modulating in situ production of energy by a biological tissue. The method comprises stimulating the biological tissue by exposing the biological tissue to a photostimulated biophotonic composition for a time sufficient to initiate the production of energy by the biological tissue.
    Type: Application
    Filed: February 8, 2018
    Publication date: November 28, 2019
    Inventors: Nikolaos LOUPIS, Remigio PIERGALLINI, David OHAYON, Lise HÉBERT, Giovanni SCAPAGNINI
  • Publication number: 20190209683
    Abstract: The present document describes methods of using compositions for inhibiting biofilm formation, or disrupting existing or developing biofilms in a subject, which composition comprises at least one chromophore and a pharmacologically acceptable carrier.
    Type: Application
    Filed: September 22, 2017
    Publication date: July 11, 2019
    Inventors: Remigio PIERGALLINI, Nikolaos LOUPIS, David OHAYON, Kevin WILKINSON, Giovanni SCAPAGNINI
  • Publication number: 20040167217
    Abstract: The invention relates to a class of compounds, and analogs thereof, which are effective in protecting cells of the central and peripheral nervous system from deterioration and cell death arising from degenerative disease, trauma, aging or like condition, disease or disorder. The methods utilize novel anti-apoptotic and neuroprotective effects for a group of natural polyphenols in cells of the central and peripheral nervous system.
    Type: Application
    Filed: April 22, 2003
    Publication date: August 26, 2004
    Inventors: Giovanni Scapagnini, Daniel L. Alkon, Vittorio Calabrese, Roberto Motterlini, Claudia Colombrita